Navigation Links
mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical
Date:1/30/2008

- New Deal Advances the Company's Groundbreaking Smart Shape Memory Polymer

(BIO-SMP(TM)) Commercialization Program -

AACHEN, Germany, Jan. 30 /PRNewswire/ -- mNEMOSCIENCE GmbH, the pioneer in the design, manufacture and commercialization of innovative, biocompatible shape memory polymers (BIO-SMP(TM)), today announced the completion of a global licensing agreement for an application of the Company's BIO-SMP(TM) with Aporo Biomedical. Based in San Francisco, Aporo Biomedical is a medical device company dedicated to delivering transformative catheter-based technologies with an initial focus on cardiovascular and vascular therapeutic areas. Aporo Biomedical will use mNEMOSCIENCE's BIO-SMP(TM) in both patent foramen ovale (PFO) and femoral artery closure devices.

"We are delighted to partner with such a skilled and innovative medical device manufacturer for our BIO-SMP(TM) technology," said Christian Palme, CEO, mNEMOSCIENCE(R). "Securing high-quality, progressive partners like Aporo Biomedical has been a key focus of our strategic development plan and represents an important milestone in advancing our BIO-SMP(TM) commercialization program."

mNEMOSCIENCE has established an industry-leading technology platform for the design and manufacture of BIO-SMP(TM). The proprietary shape memory polymers developed by mNEMOSCIENCE are unlike any other materials currently being produced and can be programmed to change shapes and rigidity when an initiating stimulus, such as change in temperature through exposure to heat sources (e.g., the human body or liquids), application of light energy or a magnetic field, or pH-change in the surrounding environment is applied. Further programmable key features include varying rates of biodegradation, proven biocompatibility and outstanding mechanical properties, all of which may overcome the limitations of other currently used materials.

"Utilizing mNEMOSCIENCE's novel BIO-SMP(TM) technology and
'/>"/>

SOURCE mNEMOSCIENCE GmbH
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...nd. - A new generation of ultrasmall transistors a...res called semiconducting nanowires are closer to ...M, Purdue University and the University of Califor...ed how to create nanowires with layers of differen... level, which is a critical requirement for making...
(Date:11/25/2009)...TON,Fla.,Nov.25/PRNewswire/--Formanybusinesses,200...,slargestandfastestgrowingnetworkofexpertphysician...denticalhormones has grownthenumberof physicians...ans -andisinprogresstoaddmorephysician-ownedcenter..., Inthepastyear ,BodyLogicMDhasopened13newbioiden...
(Date:11/25/2009)... Nov. 25 Ardea Bioscienc...ry D. Quart, Pharm.D., president and chief executi... Annual Health Care Conference. , ,Presentation d...Health Care Conference,Date: Tuesday, Decembe...on: The New York Palace Hotel, New York, NY,Webca...
(Date:11/24/2009)... The New York investment bank KTA Capital,s clie... an AU$6.7 mil convertible note private placement ...acement was arranged by KTA Capital as Neuren,s ex... New York (PRWEB) November 23, 2009 -...ital, LLC ("KTA Capital") has announced ...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...estful holiday weekend. The Memorial Day holiday i...litary service to their country. With fluttering f... most solemn of holidays. , ,Unofficially, it star...aming joyous graduates, family picnics, the Indy 5...day holds its own festive note as well. I don,t th...
...een Bay, Wis. - For six years, Steve Matheys serv...al , and his experience during that period - 1998 ...be a great training ground for bigger and better t...any entrusts you with a high level of accountabili...ve vice president of sales, marketing, and custome...
... is the 11th in a series of articles on developing...logy sectors. , , Madison, Wis. - You,ve start...some equity funds, perhaps through investors. If y...es do you have? Before discussing this point, ther...Most of us recognize that we must have some equity...
Other Biology Technology:Who is minding the Innovation Gap? 2Who is minding the Innovation Gap? 3Who is minding the Innovation Gap? 4Who is minding the Innovation Gap? 5Who is minding the Innovation Gap? 6Who is minding the Innovation Gap? 7Who is minding the Innovation Gap? 8Visions: Matheys says CIO role is good training for executive suite 2Visions: Matheys says CIO role is good training for executive suite 3Visions: Matheys says CIO role is good training for executive suite 4Early Stage: Step 11 - Other forms of finance 2Early Stage: Step 11 - Other forms of finance 3Early Stage: Step 11 - Other forms of finance 4
(Date:11/24/2009)...pus Research Institute (LRI) today named 12 new gr... million, recognize innovative work across a broad... their creativity, novelty, and potential to drive..., and cure the complex disease of systemic lupus. ... lupus researchers across the nation and include i...
(Date:11/24/2009)...omic-level action of a remarkable class of ring-sh...ers with the Lawrence Berkeley National Laboratory...rystallography beamline at the Advanced Light Sour...in gene expression and replication, and are vital ...s infectious agents, such as the human papillomavi...
(Date:11/24/2009)...constitutes fish food is a matter of debate. A hig...h get almost 50 percent of their carbon from trees...n the terrestrial and aquatic ecosystems. , But ...ws this is not likely to be true. Algae provide a ...according to research published this week in the ...
Breaking Biology News(10 mins):Lupus Research Institute announces 2009 novel research grants 2Lupus Research Institute announces 2009 novel research grants 3Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3St Louis Metro Area Optometrists Partner With Sen Bond 3B U S House Leaders in Improving Infant Eye and Vision Care 47554 1St Louis Metro Area Optometrists Partner With Sen Bond 3B U S House Leaders in Improving Infant Eye and Vision Care 47554 2St Louis Metro Area Optometrists Partner With Sen Bond 3B U S House Leaders in Improving Infant Eye and Vision Care 47554 3St Louis Metro Area Optometrists Partner With Sen Bond 3B U S House Leaders in Improving Infant Eye and Vision Care 47554 4St Louis Metro Area Optometrists Partner With Sen Bond 3B U S House Leaders in Improving Infant Eye and Vision Care 47554 5Arizona American Water and Salvation Army Offer Aid on Hottest Days 47550 1Arizona American Water and Salvation Army Offer Aid on Hottest Days 47550 2Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre Cancerous Barretts Esophagus 4507 1Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre Cancerous Barretts Esophagus 4507 2Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre Cancerous Barretts Esophagus 4507 3
...stitute of Colloids and Interfaces have presented ...ermeability of microcapsules using the salt conten... accomplish this, the researchers developed a theo...s in the polymer shell of the capsules. , This mea...mental investigations, how the properties of the h...
...revents the production of a critical blood-clottin...h genetic diseases, when they exist, may consist o...lacement therapy. But what if the body could be in...ansplanting healthy tissue with the abilities that...nt Anna Aronovich of the Weizmann Institute,s Immu...
...ells and alters the chemical makeup of the brain, ...l meeting of the Radiological Society of North Ame...o focus on the relationship between brain metaboli... from the Department of Radiology at the Universit... used proton magnetic resonance spectroscopy (MRS)...
Other Biology News:Microcapsules like it hot and salty 2Microcapsules like it hot and salty 3A transplant in time 2Smoking changes brain chemistry 2
Mouse Anti-Mouse BKBeta2 potassium channel Monoclonal Antibody, Unconjugated, Clone N53/32 from UC Davis/NINDS/NIMH NeuroMab Facility
... inhibitor (IC50 = 59.2 M). Formula: C 29 H... RT CAS: 33419-42-0 Solubility: Soluble ...aalpha,9beta(R*)]]-9-[(4,6-O-Ethylidene-beta-D-glu...3,5-dimethoxyphenyl)-furo[3',4':6,7]naphtho[2,3-d]...
Rabbit Anti-Human ALS2CR2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-IKKbeta / IKK-2 Polyclonal Antibody, Unconjugated from BioVision
Biology Products: